This series of articles is concerned with how carbohydrate, lipid and amino acid metabolism in different tissues is integrated for the benefit of the whole animal. The tissues of the body oxidize a variety of organic compounds for production of biological energy in the form of ATP. These compounds include glucose, fatty acids, ketone bodies and some amino acids and for the purpose of these articles they can be grouped together under the term metabolic fuels. They are obtained either from the diet or from storage molecules such as glycogen, triacylglycerol and protein. It is crucial for the wellbeing of the animal that at least one of these metabolic fuels is always available in the bloodstream or the tissue despite large fluctuations in the rate of fuel utilization by the tissues or in the rate of fuel production from endogenous or exogenous sources. There is a vital need for the rate of production of a fuel to be regulated precisely in relation to its rate of utilization and for the rate of production and utilization of all fuels to be satisfactorily integrated. The present series of articles presents the author's own view of how this might be achieved.
The metabolism of higher animals suffers from several disadvantages which become apparent in conditions of carbohydrate deprivation such as starvation. First, certain tissues such as red blood cells are completely dependent, and others such as brain and central nervous system are partially dependent, upon glucose as a metabolic fuel. Therefore, the supply of glucose to such tissues must be maintained. Second, the capacity of the liver to store glucose as glycogen is limited, in marked contrast to the capacity of the adipose tissue to store triacylglycerol (table I) . Liver glycogen, therefore, cannot maintain the glucose supply for prolonged periods and must be augmented by the synthesis of glucose, that is gluconeogenesis from other endogenous sources, in particular the amino acid alanine derived from the degradation of muscle protein. Third, higher animals are unable to synthesize glucose from fatty acids and as a result are unable to make use of the major portion of stored triacylglycerol for this purpose.
Nevertheless, adipose tissue triacylglycerol can contribute to the supply of glucose directly by providing glycerol, a gluconeogenic precursor, and indirectly by providing fatty acids and, ultimately, ketone bodies which are oxided in preference to glucose by some tissues. It is apparent from these considerations that complex control mechanisms are necessary for integrating the production and utilization of the various metabolites mentioned above.
Broadly speaking, the control mechanisms responsible for the conservation of glucose in conditions of carbohydrate deprivation involve inhibition of the pathways of glucose utilization and activation of the pathways of glucose production. These metabolic adaptions are integrated so that the blood glucose concentration is maintained relatively constant during starvation, in marked contrast to the fatty acid or ketone body concentrations (table II) . In this series of articles the regulation of glucose utilization through the availability of fatty acids will be discussed first and the role of muscle as the site of fatty acid utilization and adipose tissue as the site of fatty acid production will be described. Then the regulation of glucose utilization through the availability of ketone bodies will be discussed and the role of the liver in their synthesis and of brain, kidney cortex and small intestine in their utilization will be described. The regulation of glucose production will include a discussion of the role of liver glycogen and the regulation of gluconeogenesis will be discussed in relation to the muscle providing the preparation is well oxygenated (Rennie and Holloszy, 1977) . It can be concluded, therefore, that in heart, diaphragm and red skeletal muscle fatty acids are oxidized in preference to glucose and that fatty acid oxidation specifically inhibits the rate of carbohydrate utilization by these muscles. These conclusions are confirmed by studies of muscle metabolism in vivo. Under conditions such as starvation and prolonged exercise, in which the blood fatty acid concentration increases, it can be shown that the respiratory quotient decreases, indicating a shift from carbohydrate to lipid utilization. It is important to appreciate that this shift occurs in the absence of any appreciable tissues which supply gluconeogenic precursors, namely skeletal muscle, adipose tissue and red blood cells and the tissues which synthesize glucose, namely liver and kidney cortex. Finally, some ideas concerning the mechanism of action of hormones on metabolism will be described.
The inhibition of glucose utilization in muscle by the oxidation of fatty acids
Experiments with isolated in vitro muscle preparations have shown that the oxidation of fatty acids inhibits the rate of carbohydrate utilization. Thus perfusion of the isolated rat heart with fatty acids in the presence of glucose inhibits the rate of glucose uptake and glycolysis (Garland, Newsholme and Randle, 1964) . This inhibition of glucose utilization is dependent upon the oxidation of the fatty acids rather than their presence, since the inhibitory effect is abolished by respiratory poisons. Similar results were obtained using the isolated rat diaphragm. Furthermore, perfusion of the rat hindquarter with fatty acids in the presence of glucose inhibits the rate of glucose uptake and glycogen depletion in red skeletal decrease in the blood glucose concentration and hence that lipid-derived fuels are being oxidized in preference to glucose. Using arterial and coronary sinus catheterization techniques, a negative correlation between the plasma fatty acid concentration and the rate of glucose utilization by the human heart in vivo was demonstrated. A similar relationship has been shown between the rate of pyruvate oxidation by skeletal muscle during excercise and the plasma fatty acid concentration. Hence the oxidation of fatty acids by muscle in vivo inhibits glucose utilization or oxidation, or both.
The biochemical mechanism whereby the oxidation of fatty acids by muscle inhibits glucose utilization has been studied using two experimental approaches. The kinetic properties of purified key enzymes of carbohydrate utilization have been studied in vitro in order to identify possible regulator molecules. Then the concentration changes in these candidate regulator molecules are measured in the muscle in vivo. This approach identifies which of the regulators is of importance in mediating the inhibition of glucose utilization by fatty acid oxidation. The above approaches have led to the elucidation of the following sequence of events.
The oxidation of fatty acids in muscle occurs within the mitochondria and leads to an increase in the concentration ratio acetyl-CoA : CoA within this compartment. An increase in this concentration ratio inhibits the mitochondrial multienzyme complex pyruvate dehydrogenase, which converts pyruvate into acetyl-CoA. This reaction represents a loss of carbohydrate to the body since, once pyruvate has been metabolized by this enzyme to acetyl-CoA, it is committed to oxidation. Furthermore, since pyruvate that is not oxidized is released from the tissue either as lactate or alanine, which are both excellent gluconeogenic precursors, the oxidation of fatty acids in muscle conserves glucose, by inhibiting pyruvate dehydrogenase activity.
A second consequence of the increase in the mitochondrial acetyl-CoA concentration is an increase in the mitochondrial citrate concentration through the reaction catalysed by citrate synthase. Citrate can cross the inner mitochondrial membrane via a specific transport system and hence the concentration of cytoplasmic citrate also increases when fatty acids are oxidized by muscle. Citrate potentiates the inhibition, by ATP, of phosphofructokinase, a key glycolytic enzyme which catalyses the conversion of fructose-6-phosphate to fructose-1,6-diphosphate.
The inhibition of phosphofructokinase by citrate in turn leads to an accumulation of its substrate fructose-6-phosphate within the cytoplasm. Fructose-6-phosphate and glucose-6-phosphate are maintained close to equilibrium in a reaction catalysed by phosphoglucoisomerase. Consequently, an increase in the concentration of fructose-6-phosphate will be accompanied by an increase in the concentration of glucose-6-phosphate. Glucose-6-phosphate is an inhibitor of hexokinase and phosphorylase so that, when muscles oxidize fatty acids, the phosphorylation of glucose, derived either from the bloodstream or endogenous glycogen, will be inhibited.
This concerted mechanism for the inhibition of glucose utilization in muscle by the oxidation of fatty acids is illustrated in figure 1 .
The transport of glucose across the cell membrane may also be inhibited when fatty acids are oxidized by muscle, so that this provides a further control point for glucose utilization in this tissue. However, the mechanism of this effect is at present unknown.
The discussion so far has demonstrated that the provision of fatty acids to heart, diaphragm and red skeletal muscle results in their oxidation by muscle and the consequent inhibition of glucose utilization. This mechanism contributes towards the conservation of glucose in situations such as starvation where the concentration of fatty acids in the blood is high. Since the rate of fatty acid oxidation by these muscles is dependent upon the fatty acid concentration in the blood, the rate of fatty acid oxidation by muscle is controlled by the rate of mobilization of fatty acids into the bloodstream. The source of these fatty acids is adipose tissue and, therefore, factors which regulate the rate of release of fatty acids from this tissue will in turn regulate the rate of their oxidation by muscle. This subject is discussed in the next section.
For a fuller discussion of the inhibition of glucose utilization in muscle by the oxidation of fatty acids the reader is referred to Newsholme and Start (1973) .
Regulation of fatty acid mobilization from adipose tissue
Adipose tissue triacylglycerol is the major fuel reserve in man. This fuel reserve is made available to the tissues of the body as non-esterified fatty acids which are released into the blood by adipose tissue following the intracellular hydrolysis of triacylglycerol, a process referred to as lipolysis. Since fatty acids are relatively insoluble in water, they are transported in the blood bound to the protein albumin. The rate of release or mobilization of fatty acids from adipose tissue increases under certain conditions including starvation, sustained exercise and physical or psychological stress. Increased fatty acid mobilization results in two major metabolic adaptations, namely an increased rate of fatty acid oxidation in muscle and an increased rate of ketone body synthesis in the liver. It is, therefore, of crucial importance that the rate of fatty acid mobilization should be controlled in relation to the rates of fatty acid utilization by these tissues. The rate of fatty acid mobilization is regulated by a number of factors including sympathetic nervous activity, the concentration of circulating hormones (e.g. insulin) and the concentration of certain metabolites in the blood (e.g. ketone bodies, lactate). These factors are further discussed below.
The mobilization of fatty acids involves hydrolysis of triacylglycerol followed by the transport of the fatty acids across the membrane of the adipocyte. Transport occurs by simple diflFusion and is, therefore, proportional to the fatty acid concentration gradient. However, the intracellular fatty acid concentration is not determined by the rate of lipolysis only, since a proportion of the fatty acid may be esterified. Hence factors which regulate the rate of reesterification will also regulate the rate of fatty acid mobilization. Since such factors are not well understood at the present time, the following discussion will be confined to factors which regulate the rate of lipolysis and their consequent effect upon fatty acid mobilization. Nevertheless, the simultaneous activity of both the lipolytic pathway and the re-esterification pathway has an important role to play in increasing the sensitivity of control over fatty acid mobilization. This subject is also discussed below.
Adipose tissue triacylglycerol is hydrolysed to a mixture of fatty acids and glycerol in a three-step process, each step catalysed by a separate enzyme. Of the three enzymes concerned, triglyceride lipase is the most important since it catalyses a flux-generating step (Newsholme and Crabtree, 1979) . The role of such an enzyme in a metabolic pathway is to generate a flux to which all the other enzyme-catalysed reactions in the pathway respond. Triglyceride lipase generates the flux through both lipolysis in adipose tissue and fatty acid oxidation in muscle, since a change in the rate of supply of fatty acids to muscle inevitably leads to a change in the rate of their oxidation. Hence in this case the pathway concerned spans two tissues. An enzyme which catalyses a flux-generating step has several characteristics. First, it catalyses a nonequilibrium reaction in vivo and second, it approaches saturation with its substrate in vivo. As , a result the activity of the enzyme which catalyses the flux-generating step is independent of changes in the concentration of pathway-substrate and responds only to factors which are external to the pathway. Hence a flux-generating step can generate a steady-state flux to which all other reactions in the pathway adapt. It is, therefore, an extremely ' important control site. The activity of triglyceride lipase is regulated by a number of hormones, all of which act by mechanisms which involve changes in the concentration of regulators which are external to the pathway. One major difficulty in this field is the remarkable species variation in the response of lipolysis to hormones.
The hormonal regulation of adipose tissue lipolysis has been studied in vitro by measuring the rate of glycerol release from isolated adipose tissue preparations of the rat, for example epididymal fat pads or adipocytes and caution must be used in extrapolation of these findings to other animals. The results of such studies enable hormones to be classified as lipolytic or antilipolytic. Lipolytic hormones for the rat include catecholamines, glucagon, growth hormone in the presence of glucocorticoids, ACTH and possibly other pituitary hormones. Lipolytic hormones for man elude the catecholamines and TSH. Insulin and prostaglandins E ( and E 2 are antilipolytic agents in both the rat and man. Some of these hormones may be involved in the stimulation of lipolysis in vivo during conditions of stress, prolonged exercise and starvation.
The rate of fatty acid mobilization increases in response to stress and prolonged exercise. It is likely that these effects are mediated through >-increased sympathetic activity, resulting in the release of noradrenaline, a lipolytic agent, from nerve endings in the tissue. The mechanism of action of noradrenaline on triglyceride lipase activity and hence lipolysis is comparatively well understood. The initial event is the binding of noradrenaline to a receptor on the surface of the adipocyte cell membrane. This event is responsible for the activation of the membranebound enzyme adenyl cyclase which synthesizes cAMP from ATP in the cytoplasm. An increase in the concentration of cAMP activates cAMPdependent protein kinase, one of the substrates of which is triglyceride lipase. The cAMPdependent protein kinase phosphorylates triglyceride lipase at the expense of ATP and activates the enzyme since the phosphorylated form is more active than the dephosphorylated form. As a result the mobilization of fatty acids from adipose tissue increases providing tissues such as muscle with an alternative fuel to glucose. During conditions of stress and prolonged exercise, the availability of an alternative fuel allows the conservation of glucose and prevents the hypoglycaemia that could result from a massive increased demand for metabolic fuels under these conditions. During starvation, the rate of fatty acid mobilization and the plasma fatty acid concentration increase. Changes in the concentration of several circulating hormones may mediate this effect, but since lipolytic hormones are species-specific, the following discussion refers to the rat but not to man. During starvation the concentration of insulin, an antilipolytic hormone, decreases. As a consequence, lipolysis will be deinhibited. The mechanism of the inhibitory action of insulin on lipolysis is not well understood. However, insulin can decrease cAMP concentrations previously increased by lipolytic hormones, hence inhibiting cAMP-dependent protein kinase and triglyceride lipase activity. This mechanism may explain, at least in part, the antilipolytic activity of insulin. The concentration of circulating growth hormone and glucagon increases during starvation. Since both these hormones are lipolytic in the rat an increase in their concentrations may contribute towards the stimulation of lipolysis during starvation. Glucagon stimulates lipolysis by the same mechanism as catecholamines. Growth hormone, the lipolytic activity of which is seen only in the presence of glucocorticoids and takes longer to develop, acts by a different mechanism. It is thought that growth hormone stimulates the synthesis of adenyl cyclase and hence, as starvation proceeds growth hormone progressively increases the capacity of other lipolytic hormones to increase the cAMP concentration.
Changes in the concentration of circulating hormones during stress, sustained exercise and starvation may partly explain the increase in the rate of lipolysis under these conditions. However, an additional feedback control is provided by changes in the ketone body concentration. This control mechanism is discussed in more detail later on.
Isotopic techniques have shown that, in adipose tissue, the pathways of lipolysis and esterification are simultaneously active. Hence a proportion of the fatty acids formed by the hydrolysis of triacylglycerol are esterified and hence triacylglycerol is resynthesized. This triglyceride-fatty acid cycle is illustrated in figure 2 . One apparent disadvantage of this substrate cycle is that the activation of fatty acids before esterification with glycerol phosphate is an ATP-requiring reaction. Hence the operation of the triglyceride fatty acid substrate cycle consumes ATP and could be regarded as energetically wasteful. However, one advantage of this substrate cycle is that it increases the sensitivity of control over the mobilization of fatty acids from adipose tissue. Therefore, the disadvantage of ATP utilization in this cycle is balanced by the advantage of improved sensitivity of control over fatty acid mobilization. For a fuller discussion of the regulation of fatty acid mobilization adipose tissue the reader is referred to Hales, Luzio and Siddle (1978) .
The glucose-fatty acid cycle
The concept of the glucose-fatty acid cycle seeks to explain the reciprocal relationship in vivo between, on the one hand the rate of glucose utilization in muscle and, on the other hand, the rate of fatty acid mobilization from adipose tissue and oxidation in muscle. These metabolic relationships serve to maintain the blood glucose concentration relatively constant despite large changes in the rates of production and utilization of glucose. The concept of the glucose-fatty acid cycle was proposed by Randle and others (1963) . Originally the results of in vitro experiments using isolated muscle and adipose tissue preparations, some of which have been mentioned in the previous two sections, were used to formulate the theory of the glucose-fatty acid cycle which applies to the whole animal. However, evidence in support of the cycle has now been obtained from in vivo experiments. Since the concept of the glucose-fatty acid cycle was originally proposed, it has been found necessary to extend the cycle to include ketone bodies. However, in this section the original concept of the glucose-fatty acid cycle is discussed, with some evidence in support of the cycle. A discussion of the extended cycle and the physiological role of ketone bodies is provided in the next paper.
The glucose-fatty acid cycle is illustrated in figure 3 . The theory of the cycle states that when the blood glucose concentration and particularly when the liver glycogen concentration decreases, then fatty acids are mobilized from adipose tissue. As a result the blood fatty acid concentration increases and fatty acids are oxidized by muscle. The oxidation of fatty acids by muscle specifically inhibits glucose utilization in this tissue. In the original concept of the cycle an increase in the blood glucose concentration was considered to be the major factor reducing fatty acid mobilization and decreasing the blood fatty acid concentration. However, it is considered currently that the major factor responsible for reducing the mobilization of fatty acids after, for example, refeeding a starved subject, is the increase in the concentration of insulin. This causes a decrease in the rate of fatty acid oxidation in muscle so that the rate of glucose utilization increases and consequently the blood glucose concentration will be maintained close to normal ( fig. 3 ). This control mechanism allows rates of fatty acid oxidation, glucose utilization and fatty acid mobilization to be controlled by changes in the blood glucose concentration. Hence the glucose-fatty acid cycle allows the blood glucose concentration to be maintained relatively constant at the expense of the fatty acid concentration in the blood.
Some evidence for the operation of the glucose-fatty acid cycle in vivo has been obtained. First, the above theory predicts that an increase in the blood fatty acid concentration should decrease the rate of glucose utilization and hence impair glucose tolerance. The blood fatty acid concentration in human subjects in vivo can be increased either by a triglyceride meal followed by a heparin injection or by injecting noradrenaline, a lipolytic hormone. Increase of the blood fatty acid concentration by these experimental procedures decreases the rate of peripheral glucose utilization and impairs glucose tolerance. Second, the above theory predicts that, when the fatty acid concentration decreases, the rate of glucose utilization should increase and hence glucose tolerance should improve. The administration of nicotinic acid, an antilipolytic agent, to human subjects decreases the fatty acid concentration in the blood and improves glucose tolerance. Third, the above theory predicts that, if fatty acid oxidation is inhibited, the rate of glucose utilization should increase and consequently the blood glucose concentration should decrease. It has been shown that inhibitors of fatty acid oxidation such as pent-4-enoic acid when administered to human subjects are hypoglycaemic (Newsholme and Start, 1973) .
The glucose-fatty acid cycle plays a role in a number of physiological conditions. Starvation increases the fatty acid concentration in the blood as a result of an increased rate of fatty acid mobilization from adipose tissue. The fatty acids are oxidized in muscle, so inhibiting glucose utilization in this tissue. As a result glucose will be conserved for those tissues which depend upon it as a metabolic fuel, for example red blood cells. Refeeding will result in an increase in the blood glucose concentration. Hence under these circumstances the inhibition of glucose utilization in muscle must be reversed in order to prevent an excessive increase in the blood glucose concentration. Absorption of glucose from the gut causes an increase in the glucose concentration in the hepatic portal vein which stimulates the secretion of insulin. It is generally accepted that the primary role of insulin in refeeding is stimulation of the membrane transport of glucose in adipose tissue and muscle. Hence the rate of glucose utilization by these tissues increases and prevents an excessive increase in the blood glucose concentration after refeeding. This may be termed the anabolic role of insulin. However, the author considers that the antilipolytic activity of insulin may be of greater importance in promoting glucose utilization after refeeding. Insulin inhibits fatty acid mobilization from adipose tissue, which decreases the rate of fatty acid oxidation in muscle and hence increases the rate of glucose utilization in this tissue. This role of insulin in the regulation of the blood glucose concentration may be called the homeostatic role of insulin (Newsholme, 1977) . The glucose-fatty acid cycle also prevents hypoglycaemia during sustained exercise. Thus the mobilization of fatty acids during this type of exercise will inhibit glucose utilization in muscle and so conserve glucose.
The glucose-fatty acid cycle goes some way towards accounting for the relative constancy of the blood glucose concentration. However, extending the cycle to include the physiological role of ketone bodies as substrate and signal provides a more satisfactory explanation. The glucose-fatty acid ketone body cycle is discussed in the next paper (Stanley, 1981) .
For further discussion of the glucose-fatty acid cycle, the reader is referred to Newsholme (1976) .
